Skip to content

Acupuncture for Cancer Pain: a pilot pragmatic randomised controlled trial

Acupuncture for Cancer Pain: a pilot pragmatic randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017023
Enrollment
Unknown
Registered
2018-07-09
Start date
2019-03-01
Completion date
Unknown
Last updated
2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer pain

Interventions

Acupuncture Group:Acupuncture + usual care
Control group:usual care

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Consistent with the design of a pragmatic trial, the inclusion criteria are intentionally broad to reflect the heterogeneity of clinical practice. Eligible participants will be: 1. Patients admitted to the oncology inpatient department for an anticipated length of stay of at least a week; 2. 18 years of age or older; 3. With confirmed pathological diagnosis of cancer; 4. Suffering from moderate or severe cancer pain (NRS=4) at admission or during the stay.

Exclusion criteria

Exclusion criteria: 1. Contraindication to acupuncture (e.g., extreme needle phobia or severe clotting dysfunction); 2. Incapacity to consent (e.g., cognitive or communication impairment); 3. Risky medical condition (e.g., myocardial infarction, neutropenia).

Design outcomes

Primary

MeasureTime frame
Numerical rating scale (NRS);

Secondary

MeasureTime frame
Analgesic consumption;Frequency of breakthrough pain and rescue medication used;Edmonton Symptom Assessment System (ESAS);Adverse events;

Countries

China

Contacts

Public ContactHaibo Zhang

Guangdong Provincial Hospital of Chinese Medicine

haibozh@aliyun.com+86 20-81887233-34829

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 5, 2026